For the treatment of patients with relapsing forms of multiple sclerosis to include clinically isolated syndrome, relapsing remitting disease, and active secondary progressive disease, in adults.
Aubagio
$382.50 – $1,437.60
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.